Apyx Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Apyx Medical (APYX).

Price Target Range — 4 Quarters

Analyst Consensus — 8 Analysts

1S.Buy

6Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$6Upside to Avg. PT+145.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2026	Maxim Group	—	Initiate	Buy	$6
Jul 13, 2026	HC Wainwright & Co.	Yi Chen	Initiate	Buy	$7
Mar 11, 2026	Craig-Hallum	Matthew Hewitt	PT Raise	Buy	$5→$6
Mar 11, 2026	BTIG	Sam Eiber	Upgrade	Neutral→Buy	$6
Dec 16, 2025	Roth Capital	Kyle Bauser	Initiate	Buy	$6
Nov 12, 2025	Citizens	David Turkaly	Upgrade	Market Perform→Market Outperform	$8
Oct 17, 2024	BTIG	Sam Eiber	Initiate	Neutral	—
Sep 16, 2024	JMP Securities	David Turkaly	Maintained	Market Perform	—
Nov 10, 2023	Stephens & Co.	George Sellers	PT Cut	Overweight	$8→$5

Analyst Ratings News

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Wall Street analysts changed outlook on top stocks. To see all changes, visit the analyst ratings page. FAST stock has a Buy rating with $55 PT.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Craig-Hallum Maintains Buy on Apyx Medical, Raises Price Target to $6

Craig-Hallum analyst Matthew Hewitt maintains Apyx Medical (NASDAQ:APYX) with a Buy and raises the price target from $5 to $6.

Benzinga Newsdesk

This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised price targets. See analyst ratings page.

Avi Kapoor

PRO
BTIG Upgrades Apyx Medical to Buy, Announces $6 Price Target

BTIG analyst Sam Eiber upgrades Apyx Medical (NASDAQ:APYX) from Neutral to Buy and announces $6 price target.

Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6

Roth Capital analyst Kyle Bauser initiates coverage on Apyx Medical (NASDAQ:APYX) with a Buy rating and announces Price Target of $6.

Benzinga Newsdesk

Apyx Medical Corp

Apyx Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

PRO
Craig-Hallum Maintains Buy on Apyx Medical, Raises Price Target to $6

This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

PRO
BTIG Upgrades Apyx Medical to Buy, Announces $6 Price Target

PRO
Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6

People Also Watch

People Also Watch

Apyx Medical Corp

Apyx Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROHC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

PROCraig-Hallum Maintains Buy on Apyx Medical, Raises Price Target to $6

This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

PROBTIG Upgrades Apyx Medical to Buy, Announces $6 Price Target

PRORoth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

PRO
Craig-Hallum Maintains Buy on Apyx Medical, Raises Price Target to $6

PRO
BTIG Upgrades Apyx Medical to Buy, Announces $6 Price Target

PRO
Roth Capital Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $6